Product

TCRαβ+/CD19+ depleted allogeneic hematopoietic stem cell transplant

1 clinical trial

1 indication

Indication

Allogeneic Hematopoietic Cell Transplantation

Clinical trial

Safety and Efficacy of TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders in Children and Adolescent/Young Adult Patients

Status: Terminated, Estimated PCD: 2021-05-14